Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
923.62
+2.74 (+0.30%)
Streaming Delayed Price
Updated: 11:26 AM EDT, Sep 12, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Pfizer Just Confirmed It's a Dividend Investor's Dream Stock
August 01, 2024
This big pharma stock gives investors juicy and reliable dividends plus the potential for future growth.
Via
The Motley Fool
Pfizer to Buy a GLP-1 Drugmaker? Here's Why You Shouldn't Count on That Happening
August 01, 2024
Pfizer's debt load could inhibit the company's ability to take on acquisitions in the near term.
Via
The Motley Fool
The Top 3 Healthcare Stocks to Buy Now: Summer 2024
July 31, 2024
Investors should consider the long term prospects of the following three healthcare stocks as the U.S. population ages.
Via
InvestorPlace
What's Going On With Eli Lilly Today?
July 30, 2024
Eli Lilly & Co shares are trading lower Tuesday. Here's what you need to know.
Via
Benzinga
3 Biotech Stocks That Could Make Your Summer Unforgettable
July 30, 2024
If you want to do well with biotech stocks, trade the anticipation of news. Here are three stocks to consider.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
July 30, 2024
Via
Benzinga
This Is What Whales Are Betting On Eli Lilly and Co
July 30, 2024
Via
Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly and Co
July 29, 2024
Via
Benzinga
Unlocking the Next 3 Trillion-Dollar Stock Opportunities
July 30, 2024
Investors might want to consider the potential of these three superstars poised to become future trillion dollar stocks.
Via
InvestorPlace
1 Weight Loss Pharma Stock to Buy, and 1 to Consider
July 30, 2024
There's more than one type of worthy opportunity in this space.
Via
The Motley Fool
Healthy Profits: 7 Healthcare Stocks to Build a Lifetime of Wealth
July 30, 2024
Healthcare stocks offer wealth to investors through a mix of steady performance, growth and income not to be overlooked.
Via
InvestorPlace
DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?
July 30, 2024
DexCom faces several challenges, but GLP-1 drugs aren't big problems for the company right now.
Via
The Motley Fool
Eli Lilly’s $123 Billion Market Value Drop: A Strategic Buying Opportunity?
July 29, 2024
JPMorgan analyst says Eli Lilly will remain a leader in weight loss drugs.
Via
Talk Markets
Is Eli Lilly Stock a Buy?
July 28, 2024
The stock is up 250% in three years on growth in GLP-1 medications.
Via
The Motley Fool
Analyzing Eli Lilly and Co In Comparison To Competitors In Pharmaceuticals Industry
July 26, 2024
Via
Benzinga
3 Overlooked Stocks Poised for a Breakout Very Soon
July 29, 2024
Discover three overlooked breakout stocks with solid growth prospects, perfect for enhancing your investment portfolio.
Via
InvestorPlace
What Will Be the Best Weight Loss Drug Stock of 2030: Eli Lilly, or Novo Nordisk?
July 29, 2024
There's reason to believe that one of these two players will eventually win.
Via
The Motley Fool
Weight Loss Drug Stocks Just Took a Hit. Should You Buy the Stock That Caused It?
July 29, 2024
Roche's latest breakthrough could be a game changer, but it's still too early to say.
Via
The Motley Fool
Attention, Growth Investors: This Biotech Stock Is Crushing Nvidia.
July 29, 2024
Should you get in on this stock now?
Via
The Motley Fool
7 Smart Stocks to Buy BEFORE They Report Q2 Earnings
July 28, 2024
If you want to make the right moves in the next couple of weeks, consider buying the best stocks to buy before earnings reports are final.
Via
InvestorPlace
Home Depot Stock Turned $1,000 Into $17.5 Million, and One of Its Founders Just Revealed His Investing Secrets to Achieve Generational Wealth
July 28, 2024
Home Depot founder Ken Langone recently shared his investment wisdom on the American Optimist podcast.
Via
The Motley Fool
Week In Review: Nanjing Triastek Partners With BioNTech In A $1.2 Billion Drug Development Deal
July 27, 2024
Triastek will develop oral RNA therapeutics with Germany’s BioNTech based on its 3D printing technology. Triastek will receive a $10 million upfront payment and up to $1.2 billion in milestones, plus...
Via
Talk Markets
Novo Nordisk's Next-Gen Diabetes Candidate Could Challenge Ozempic -- Is the Stock a Buy?
July 27, 2024
The company should maintain its lead in this growing area.
Via
The Motley Fool
These 2 Growth Stocks Are Set to Soar This Summer and Beyond
July 27, 2024
It's a great time to invest in wonderful stocks.
Via
The Motley Fool
Bull Market Buys: 2 Growth Stocks to Own for the Long Run
July 27, 2024
These companies are no strangers to beating the market.
Via
The Motley Fool
SPDR ETF Report For Friday, July 26
July 27, 2024
In this video, Ira Epstein reviews the day's trading in various SPDR-ETF markets for the trading day that ended, Friday, July 26.
Via
Talk Markets
Topics
ETFs
Stock Market Diverges, With Tesla, Google, ServiceNow, GE In Focus: Weekly Review
July 26, 2024
Small caps continued to lead, while the Nasdaq broke below key levels.
Via
Investor's Business Daily
Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side Events
July 26, 2024
The European Medicines Agency's CHMP has rejected the approval of Eisai and Biogen's Alzheimer's treatment lecanemab, citing concerns over its risks. Eisai plans to appeal the decision and work towards...
Via
Benzinga
Biogen Stock Tumbles After European Regulators Unexpectedly Reject Alzheimer's Drug
July 26, 2024
Biogen partner Eisai is planning to ask European regulators to re-examine their decision.
Via
Investor's Business Daily
Prediction: This Is What Eli Lilly Stock Will Do Next
July 26, 2024
Shares of Eli Lilly are up more than 130% in the past year, but this company's moves are far from finished.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.